Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8680900

Download in:

View as

General Info

PMID
8680900